GF/B11/DP19
Approved by the Board on: 29 September 2005
Budget for the Quality Assurance of Limited and Single-Source Products Board Decision
The Board approves an addition to the 2005 budget of US$ 380,000 for the estimated costs of implementing the quality assurance policy for single and limited source pharmaceutical products. This amount is an upper limit pending experience of the extent to which random testing is required.
The Board notes that the Secretariat will continue to engage with WHO and other partners in order to optimize the process. The Finance and Audit Committee shall review the 2006 cost estimates in conjunction with the 2006 Secretariat budget process, and shall review the actual costs of implementation towards the end of 2006 and adjust the budget accordingly if warranted.
Budgetary Implications
The budgetarv implications of this decision are US$ 380,000.